Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 29 Clinics in the Bellin Health health system


The results below represent the care of 2,879 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ALGOMA NURSING HOME PROGRAM

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH CRIVITZ

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH DAGGETT

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ALGOMA

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ASHWAUBENON
N=625
96.96 %
View Historical Data
BELLIN HEALTH FMC ASHWAUBENON IM AND PEDIATRICS
N=197
96.45 %
View Historical Data
BELLIN HEALTH FMC BELLEVUE
N=270
97.78 %
View Historical Data
BELLIN HEALTH FMC BONDUEL

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC BRILLION

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC DE PERE EAST
N=282
97.52 %
View Historical Data
BELLIN HEALTH FMC DE PERE WEST
N=138
97.83 %
View Historical Data
BELLIN HEALTH FMC DENMARK

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ESCANABA
N=162
95.68 %
View Historical Data
BELLIN HEALTH FMC HOWARD
N=261
98.85 %
View Historical Data
BELLIN HEALTH FMC IRON MOUNTAIN
N=340
94.71 %
View Historical Data
BELLIN HEALTH FMC KEWAUNEE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC LUXEMBURG

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC MANITOWOC

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC OCONTO

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC OCONTO FALLS
N=130
98.46 %
View Historical Data
BELLIN HEALTH FMC PULASKI

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC SEYMOUR

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC SURING

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC WEBSTER AVE AND CLINICA HISPANA

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC WRIGHTSTOWN

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH MARINETTE
N=474
95.78 %
BELLIN HEALTH MENOMINEE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH PESHTIGO

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH STURGEON BAY

The number of patients or providers is too small for
purposes of reliably reporting performance

There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease.

Based on trials involving other secondary prevention therapies, the ACC and AHA recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions.

This measure shows the percentage of people 18 to 75 years of age with a diagnosis coronary or other atherosclerotic vascular disease who were prescribed oral antiplatelet therapy, unless contraindicated, in the measurement year.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.